Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
patients
100%
mortality
75%
therapy
54%
diseases
49%
covid-19
38%
coronaviruses
31%
anticoagulants
26%
risks
26%
fractures
25%
comparative evaluations
24%
emergencies
18%
females
17%
units
17%
adults
16%
inflammation
12%
performance
12%
prediction
12%
kyrgyzstan
12%
tuberculosis
12%
therapeutic doses
11%
fibrinogen
10%
women
9%
concentration
9%
dimers
9%
ferritin
9%
education
8%
policy
8%
reduction
8%
transmission
8%
interventions
8%
Keyphrases
COVID-19
60%
Antithrombotic Therapy
51%
Nursing Home Residents
38%
Coronavirus Disease (COVID)
27%
Maastricht
27%
Intensive Care
25%
Pulmonary Embolism
25%
Multicenter Retrospective Cohort Study
25%
Hip Fracture
25%
Mortality Risk
19%
Emergency Department
18%
Anticoagulants
15%
Hypercoagulability
14%
Hypofibrinolysis
12%
Inflammation
12%
Rotational Thromboelastometry (ROTEM)
12%
Fracture Type
12%
Mechanically Ventilated Patients
12%
EXTEM
12%
FIBTEM
12%
Respiratory Decline
12%
Diabetes Type 1
12%
Diabetes Mortality
12%
Short-term Outcomes
12%
Prediction Model
12%
Anticoagulation
12%
COVID-19 Patients
12%
SARS-CoV-2 Infection
12%
Coagulation
12%
Older Adults
12%
Medicine and Dentistry
COVID-19
61%
Pulmonary Embolism
25%
Intensive Care
25%
Hip Fracture
25%
Antithrombotic Therapy
25%
Emergency Department
18%
Comorbidity
17%
Nursing Home
14%
Hypercoagulability
13%
Prevalence
12%
Retrospective Study
12%
Thromboelastometry
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Diabetes
12%
Anticoagulation
12%
Infection
12%
Esophagitis
12%
Intensive Care Unit
12%
Fibrinogen
10%
Vitamin K Antagonist
9%
Ferritin
9%
D-Dimer
9%
Thromboembolism
8%
C Reactive Protein
7%
Deterioration
7%
Rare Disease
6%
Health Outcomes
6%
Fibrinolysis
5%
Antiplatelet
5%
Direct Oral Anticoagulant
5%